NCT07018206View on ClinicalTrials.gov

Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Axial Spondylarthritis (axSpA)

Interventions

DRUG

Upadacitinib 15 MG [Rinvoq]

15mg tablet once per day

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

CARE ARTHRITIS LTD.

INDUSTRY